Last reviewed · How we verify
rSIFN-co Nasal Spray
rSIFN-co Nasal Spray is a Small molecule drug developed by Sichuan Huiyang Life Science and Technology Corporation. It is currently in Phase 2 development. Also known as: rSIFN-co.
At a glance
| Generic name | rSIFN-co Nasal Spray |
|---|---|
| Also known as | rSIFN-co |
| Sponsor | Sichuan Huiyang Life Science and Technology Corporation |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- rSIFN-co Nasal Spray CI brief — competitive landscape report
- rSIFN-co Nasal Spray updates RSS · CI watch RSS
- Sichuan Huiyang Life Science and Technology Corporation portfolio CI
Frequently asked questions about rSIFN-co Nasal Spray
What is rSIFN-co Nasal Spray?
rSIFN-co Nasal Spray is a Small molecule drug developed by Sichuan Huiyang Life Science and Technology Corporation.
Who makes rSIFN-co Nasal Spray?
rSIFN-co Nasal Spray is developed by Sichuan Huiyang Life Science and Technology Corporation (see full Sichuan Huiyang Life Science and Technology Corporation pipeline at /company/sichuan-huiyang-life-science-and-technology-corporation).
Is rSIFN-co Nasal Spray also known as anything else?
rSIFN-co Nasal Spray is also known as rSIFN-co.
What development phase is rSIFN-co Nasal Spray in?
rSIFN-co Nasal Spray is in Phase 2.
Related
- Manufacturer: Sichuan Huiyang Life Science and Technology Corporation — full pipeline
- Also known as: rSIFN-co
- Compare: rSIFN-co Nasal Spray vs similar drugs
- Pricing: rSIFN-co Nasal Spray cost, discount & access